Mary is a Postdoctoral Research Associate working at University of Central Lancashire and Imperial College London. She has always been interested in scientific research but was even more fascinated by how research can be directly translated for patient benefits. Her main research interests include the use of technologies that have the potential to facilitate the diagnosis of neurodegenerative diseases, such as Alzheimer's disease, as well as diagnose and improve clinical outcomes of female malignancies, including cervical, ovarian and endometrial cancers.
Mary completed a PhD in Biomedical Sciences during which she developed an interest in translational research. During her current postdoctoral post at the University of Central Lancashire, she investigates innovative approaches to accurately diagnose Alzheimer's disease using minimally-invasive biological fluids.
Mary is an ongoing member of research and clinical teams and within the last years, she has authored and been involved in more than 25 publications, some of which have also attracted press interest (BMJ; Annals Oncol; Nat Prot; PNAS). She has been an author of peer-reviewed publications, book chapters and reviews. She has given over 30 presentations at national & international meetings. These included both oral and poster presentations at conferences relevant to her research field. She has been an Associate Supervisor for several MSc and PhD research projects during her PhD/Postdoctoral post.
- Research Associate, Imperial College London, 2019 (on-going)
- PhD Biomedical Sciences, Lancaster University/UCLan, 2018
- BSc Chemistry, University of Ioannina, Greece, 2015
- Young Investigator Grant, 2019